GamaMabs Pharma

PharmaceuticalsSeries CToulouse, Francegamamabs.com

Latest round

Series C

Last raised

Jul 2020

Total raised

$26M

Investors

5

About GamaMabs Pharma

GamaMabs Pharma is based in France and focuses on the development of therapeutic antibodies to treat gynaecological cancers.

Who invested in GamaMabs Pharma

5 investors across 3 rounds

See all investors in GamaMabs Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jul 16, 2020

    Amount

    $4.9M

    Investors

    Locked

  2. Series B

    Jun 20, 2018

    Amount

    $4.1M

    Investors

    Locked

  3. Series B

    Mar 16, 2016

    Amount

    $17M

    Investors

    Locked

Questions about GamaMabs Pharma

Who invested in GamaMabs Pharma?

GamaMabs Pharma has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has GamaMabs Pharma raised?

GamaMabs Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did GamaMabs Pharma last raise money?

GamaMabs Pharma's most recent round on record is a Series C, in Jul 2020.

What does GamaMabs Pharma do?

GamaMabs Pharma is based in France and focuses on the development of therapeutic antibodies to treat gynaecological cancers.

Where is GamaMabs Pharma headquartered?

GamaMabs Pharma is headquartered in Toulouse, France.

Which VCs invest in companies like GamaMabs Pharma?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at GamaMabs Pharma's stage. Their profiles are linked below.

Raising like GamaMabs Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.